EN
Home/Canada/Compare/Rybelsus vs Ozempic in Canada: is the pill the same as the injection?
CACanada Medicines

Rybelsus vs Ozempic in Canada: is the pill the same as the injection?

The same medicine as a daily tablet or a weekly injection: how each is taken, what their trials showed, what they cost and which plans cover them.

GLP Guidebook teamPublished 14 Oct 20268 min read13 sourcesWritten from published sources
What we checked13 sources, each one opened and linked to the sentence it supportsLast checked 14 Oct 2026 · Next review due 14 Apr 2027 · How we write

Written for Canada, from Canadian sources.

The short answer

Yes and no. Rybelsus and Ozempic both contain semaglutide and are approved in Canada for type 2 diabetes, but Rybelsus is a daily tablet taken on an empty stomach and Ozempic is a weekly injection. We found no trial comparing them directly. Ontario lists Rybelsus at $7.53 a tablet and Ozempic at $227.94 a pen.

At a glance

RybelsusOzempic
Medicine and makerSemaglutide tablets, Novo Nordisk1Semaglutide injection, Novo Nordisk2
Approved in Canada forType 2 diabetes in adults, including lowering heart risks in those with heart disease or at high risk1Type 2 diabetes in adults, including lowering heart and kidney risks in some people with type 2 diabetes2
How it’s takenOne tablet a day, on an empty stomach, at least 30 minutes before food, drink or other pills, with up to 120 mL of water1Injection under the skin once a week, from a multi-dose pen2
Dose steps3 mg for 30 days, then 7 mg; 14 mg if needed. Newer tablets: 1.5, 4 and 9 mg, the same steps10.25 mg for 4 weeks, then 0.5 mg; 1 mg and then 2 mg if needed2
Weight change in a placebo-controlled trialPIONEER 1, 26 weeks: −2.3 kg on 7 mg and −3.7 kg on 14 mg vs −1.4 kg on a dummy pill111 to 20 in 100 felt sick, against 6 in 100SUSTAIN 9, 30 weeks: −4.1 kg on 1 mg vs −1.0 kg on a dummy injection220 in 100 felt sick on 1 mg, against 6 in 100 on comparisons
Most common side effectsNausea and diarrhea: very common, more than 1 in 10 (EU Rybelsus label)3Nausea and diarrhea: very common, more than 1 in 10 (EU Ozempic label)4
Official price$7.5303 a tablet at every strength (Ontario formulary): about $228 a month, $2,741 a year5$227.94 a pen (Ontario formulary): about $247 a month, $2,963 a year at 0.5 or 1 mg. Generic semaglutide $78.14 a pen5
Coverage in CanadaLimited Use in Ontario and for First Nations and Inuit; not a benefit in BC5,6,7Covered with criteria in Ontario, BC, Quebec, and for First Nations and Inuit8,9,6

Side by side, not ranked. The trials were separate, so their numbers can’t be compared directly. Prices: a year is 364 days of tablets, or 13 pens of 4 weekly doses; a month is a twelfth of a year; our arithmetic. Pharmacies add their own markup and fees. Checked 14 Oct 2026.

Key takeaways

  • Rybelsus and Ozempic both contain semaglutide from Novo Nordisk, and both are approved in Canada for adults with type 2 diabetes.1,2
  • Rybelsus is one tablet a day, taken on an empty stomach at least 30 minutes before food, drink or other pills, with no more than 120 mL of water.1
  • Only about 1 to 2% of the semaglutide in a Rybelsus tablet is absorbed, which is why tablet doses are much larger than injection doses.1
  • We found no trial comparing Rybelsus directly with Ozempic; their own trials were separate, so their results can’t be compared directly.1,2
  • Ontario lists Rybelsus at $7.5303 a tablet and Ozempic at $227.94 a pen of 4 weekly doses.5
Before you go further
  • GLP‑1 medicines are prescription drugs in Canada. Nothing here is a reason to start, stop or switch one.10
  • We name brands and official prices as facts. We don’t recommend, rank or link to any brand, pharmacy, clinic or program.
  • Canadian law bans advertising any drug to the general public as a treatment, preventative or cure for obesity or diabetes.11 This page is information, not an ad, and nothing here is for sale.
  • Trial results are averages. Some people lose much less, and every benefit comes with risks: see our side effects guide.
On this page
  1. Are Rybelsus and Ozempic the same medicine?
  2. How is each one taken?
  3. What did their trials show?
  4. How much do they cost, and who covers them?
  5. Which one? What does a doctor weigh?
  6. Questions people ask
  7. How we researched this
  8. Sources

Are Rybelsus and Ozempic the same medicine?

Yes, both are semaglutide from Novo Nordisk. Rybelsus is a daily tablet and Ozempic a weekly injection, and both are approved for type 2 diabetes.1,2

The medicine is what works in your body; the brand is the name on the box. Wegovy is semaglutide too, as a weekly injection for weight management.12

Semaglutide is hard to absorb from the gut. Only about 1 to 2% of a tablet’s dose reaches the blood, so Rybelsus adds an absorption enhancer called SNAC and uses much larger doses: 7 or 14 mg a day, against 0.5 to 2 mg a week for Ozempic.1,2

How is each one taken?

Rybelsus is swallowed whole once a day on an empty stomach, at least 30 minutes before the first food, drink or other pills of the day.1

  • Water: no more than half a glass, 120 mL. More water lowers the amount absorbed.1
  • Don’t split, crush or chew the tablet.1
  • Missed dose: skip it and take the next one the following day.1

Ozempic is injected under the skin once a week, at any time of day, with or without meals. A missed dose can be taken within 5 days; after that, skip it.2

The newer Rybelsus tablets (1.5, 4 and 9 mg) replace 3, 7 and 14 mg dose for dose. Taking two tablets to make a higher dose is not recommended.1

What did their trials show?

We found no trial comparing the two directly. In their own trials, against a dummy treatment, both lowered blood sugar and weight in people with type 2 diabetes.1,2

HbA1c is your average blood sugar over about 3 months.

  • Rybelsus (PIONEER 1, 26 weeks): HbA1c fell 1.2 points on 7 mg and 1.4 on 14 mg, against 0.3 on a dummy pill. Weight fell 2.3 and 3.7 kg, against 1.4 kg.1
  • Ozempic (SUSTAIN 9, 30 weeks): HbA1c fell 1.3 points on 1 mg, against 0.2 on a dummy injection. Weight fell 4.1 kg, against 1.0 kg.2

These trials had different people, lengths and other medicines, so their numbers can’t be compared directly.

RisksThe risks, in brief
  • Stomach effects are very common (more than 1 in 10 people) on the EU Rybelsus and Ozempic labels, mostly while the dose goes up.3,4
  • Low blood sugar is more likely when either is taken with insulin or a sulfonylurea, such as gliclazide.1,2
  • Pancreatitis (an inflamed pancreas) is rare (up to 1 in 1,000) on the EU Rybelsus label and uncommon (up to 1 in 100) on the EU Ozempic label: severe stomach pain that won’t go away.3,4
  • Diabetic eye disease can get worse for a while when blood sugar improves quickly. In pooled Rybelsus trials, eye problems from diabetes were reported in 4.2 in 100 people on Rybelsus, against 3.8 in 100 on comparison treatments.1
  • Thyroid and pregnancy. Neither is for anyone with a personal or family history of medullary thyroid cancer or MEN 2.1,2
Full detail in our side effects guide →
Get help now: call 911 or go to the nearest emergency department for severe stomach pain that won’t go away, with or without vomiting. It can be pancreatitis. Not sure? Call 811 to speak to a nurse in most provinces (Info-Santé 811 in Quebec).13

How much do they cost, and who covers them?

Ontario lists every Rybelsus strength at $7.5303 a tablet and Ozempic at $227.94 a pen. Generic semaglutide, a generic of Ozempic, is $78.14 a pen.5

Over a year, that is about $2,741 for Rybelsus (364 tablets) and $2,963 for Ozempic (13 pens), by our arithmetic.5 No generic Rybelsus is listed in Canada.10

Ozempic is covered for type 2 diabetes with criteria in Ontario, BC and Quebec, and for First Nations and Inuit.8,9,6 Rybelsus is Limited Use in Ontario and for First Nations and Inuit, but BC listed it as a non-benefit in 2023.5,6,7 See coverage by province.

Free toolWork out a year’s medicine cost

Official Canadian prices, dose by dose. Free, no sign-up.

Open the calculator

Which one? What does a doctor weigh?

We don’t recommend either. These are the points a doctor and a person with type 2 diabetes usually talk through, from the Canadian labels and plans.

  • Needles or tablets. Some people prefer a daily tablet; others a weekly injection.1,2
  • The morning routine. Rybelsus needs an empty stomach and a 30-minute wait before eating, drinking or other pills.1
  • Other medicines. Many morning pills must wait 30 minutes after Rybelsus; insulin or a sulfonylurea raises the risk of low blood sugar with either.1,2
  • Kidney and heart uses. Ozempic’s label adds kidney outcomes in type 2 diabetes with chronic kidney disease.2
  • Coverage. In BC, Rybelsus is not a benefit; Ozempic is, with Special Authority.7,9

Our type 2 diabetes path walks through the questions to bring.

Questions people ask

Is Rybelsus the same as Ozempic?

Same medicine, semaglutide, from the same maker. Rybelsus is a daily tablet and Ozempic a weekly injection; both are approved in Canada for type 2 diabetes.1,2

Is Rybelsus as effective as Ozempic?

We found no trial comparing them directly. Each lowered blood sugar and weight against a dummy treatment in its own trials, which can’t be compared directly.1,2

Is there a Wegovy pill in Canada?

No. On 14 October 2026, the only semaglutide tablets in Health Canada’s database were Rybelsus, for type 2 diabetes.10

How does the cost of Rybelsus compare with Ozempic?

On Ontario’s formulary, a year of Rybelsus comes to about $2,741 and a year of Ozempic to about $2,963, by our arithmetic. Your plan and pharmacy fees change what you pay.5

Is Rybelsus approved for weight loss in Canada?

No. Rybelsus is approved for type 2 diabetes. The semaglutide brand approved for weight management is Wegovy.1,12

How we researched this

We compared the Canadian product monographs for Rybelsus (13 July 2026) and Ozempic (13 July 2026), the EU package leaflets for frequency bands, and Health Canada’s Drug Product Database on 14 October 2026.

Prices are from Ontario’s formulary, checked 14 October 2026. Coverage is from Ontario’s formulary, BC PharmaCare decisions and Diabète Québec’s March 2026 table.

Before you move on

  • Check which brand and strength is on your prescription.
  • If you take Rybelsus, plan the 30-minute wait before breakfast and other pills.
  • Ask your plan which one it covers, and on what criteria.
  • Never use two GLP‑1 medicines together.
  • Know the warning signs in the risks box.
Cost calculatorWhat GLP‑1s doSide effects and risks

More from the Canada blog

CACanadaDoes your province cover Ozempic? Ontario, BC, Alberta, Quebec and others comparedCACanadaHow much do Ozempic, Wegovy, Mounjaro and Zepbound cost in Canada?CACanadaWhich generic versions of Ozempic and Wegovy are approved in Canada?
About GLP Guidebook

The monthly Canada update

An independent guide to GLP‑1 medicines. We don’t sell medicines, take drug-company money, earn commissions or link to any provider. Once a month: Health Canada approvals, recalls, provincial coverage changes and official prices. How we write

Was this page easy to understand?

Sources

  1. Novo Nordisk Canada. Rybelsus (semaglutide tablets) Product Monograph, 13 July 2026 (type 2 diabetes; 3 mg for 30 days, then 7 mg, then 14 mg if needed, or 1.5, 4 and 9 mg in the newer tablets; empty stomach, at least 30 minutes before food, with no more than 120 mL of water; PIONEER 1 results; Table 3: nausea 11.0% on 7 mg and 19.7% on 14 mg vs 6.4% on placebo; diabetic retinopathy events 4.2% vs 3.8% in pooled trials, and temporary worsening with rapid improvement in glucose; about 1–2% absolute bioavailability; SNAC absorption enhancer; missed dose skipped; aspiration warning). PDF
  2. Novo Nordisk Canada. Ozempic (semaglutide injection) Product Monograph, 13 July 2026 (type 2 diabetes indications, including reducing the risk of major heart and blood-vessel events in adults with type 2 diabetes and heart or chronic kidney disease, and of kidney decline in type 2 diabetes with chronic kidney disease; GLP‑1 receptor agonist; 0.25 mg for 4 weeks, then 0.5 mg, then 1 mg and 2 mg if needed, maximum 2 mg; SUSTAIN 2 and SUSTAIN 9 results; Table 2 adverse reactions: nausea 17.0% on 0.5 mg and 19.9% on 1 mg vs 6.3% on comparators; once weekly “at any time of the day, with or without meals”; missed dose within 5 days; stop at least 2 months before a planned pregnancy; perioperative aspiration warning). PDF
  3. European Medicines Agency. Rybelsus: EPAR product information (package leaflet section 4: nausea and diarrhea “very common (may affect more than 1 in 10 people)”; gallstones “uncommon”; acute pancreatitis “rare (may affect up to 1 in 1 000 people)”). PDF
  4. European Medicines Agency. Ozempic: EPAR product information (package leaflet section 4: nausea and diarrhea “very common (may affect more than 1 in 10 people)”; vomiting and gallstones “common”; acute pancreatitis “uncommon (may affect up to 1 in 100 people)”). PDF
  5. Ontario Ministry of Health. Ontario Drug Benefit Formulary search (Ozempic $227.94 a pen, with the plan paying $78.141; Apo-Semaglutide and Dr. Reddy’s semaglutide $78.141 a pen; Sevmia $325.048 a pen and Wegovy with no price, both “Off-Formulary Interchangeable”; Rybelsus $7.5303 a tablet at every strength; no tirzepatide). Checked 14 October 2026. Link
  6. Diabète Québec. Table of diabetes medications and their coverage, March 2026 (RAMQ: Ozempic an exception drug “in association with MET, where a SU is contraindicated, not tolerated or ineffective”; Mounjaro private insurance only; NIHB: Ozempic and Rybelsus Limited Use). A secondary source: we could not reach the RAMQ list itself. PDF
  7. BC PharmaCare. Drug coverage decision: semaglutide (Rybelsus), “Non-Benefit”, 31 January 2023 (pCPA negotiations “could not be reached”; Ozempic covered as a Limited Coverage benefit). PDF
  8. Ontario Ministry of Health. Executive Officer Notice, 26 January 2024: semaglutide (Ozempic) Limited Use for adults with type 2 diabetes when blood sugar isn’t controlled on the maximum tolerated dose of metformin, or metformin can’t be used. PDF
  9. BC PharmaCare. Limited coverage drugs: semaglutide (Special Authority for type 2 diabetes after inadequate control on maximum tolerated metformin; coverage up to 1 mg weekly; 2 mg under review). Checked 14 October 2026. Link
  10. Health Canada. Drug Product Database: product records, schedule, route and status for every semaglutide, tirzepatide, liraglutide and dulaglutide product (all on the “Prescription” schedule; all subcutaneous injections or oral tablets; for example Sevmia “Approved”, not marketed; first generic semaglutide marketed 6 May 2026). Searched 14 October 2026. Link
  11. Food and Drugs Act (R.S.C., 1985, c. F-27), section 3(1): “No person shall advertise any food, drug, cosmetic or device to the general public as a treatment, preventative or cure for any of the diseases … referred to in Schedule A.1”; Schedule A.1 lists diabetes and obesity. Justice Laws Website. Checked 14 October 2026. Link
  12. Novo Nordisk Canada. Wegovy (semaglutide injection) Product Monograph, 2 October 2026 (indications; dose escalation 0.25, 0.5, 1, 1.7 mg every 4 weeks to 2.4 mg; reassess after 12 weeks on the maintenance dose; STEP 1–3 results; Table 4: nausea 44% vs 16% on placebo; perioperative aspiration warning). PDF
  13. Heart and Stroke Foundation of Canada. Medical services by phone (811 in most provinces and Yukon; Info-Santé 811 in Quebec). Checked 12 October 2026. Link

Last checked 14 Oct 2026 · Next review due 14 Apr 2027 · Report an error

How this page was made. Written by the GLP Guidebook team from the sources above. Prices are official list, formulary or maker-submitted prices, never a pharmacy, clinic, savings-card or coupon price. Figures marked as our arithmetic are worked out from those sources. It’s general information, not medical advice, and not an advertisement for any medicine. Talk to your family doctor, nurse practitioner or pharmacist before starting, stopping or changing any medicine. We don’t sell, prescribe or recommend any brand or provider. How we write